Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chem Commun (Camb) ; 60(53): 6753-6756, 2024 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-38863330

RESUMO

An efficient Rh(III)-catalyzed enantioselective C-H alkynylation of isoquinolines is disclosed. The C-H alkynylation of 1-aryl isoquinolines with hypervalent iodine-alkyne reagents proceeded in DMA at room temperature in the presence of 2.5 mol% chiral SCpRh(III) complex along with 20 mol% AgSbF6, providing axially chiral alkynylated 1-aryl isoquinolines in excellent yields (up to 93%) and enantioselectivity (up to 95% ee). The diverse transformations of the product further enhance the potential utility of this reaction.

2.
ACS Cent Sci ; 9(11): 2036-2043, 2023 Nov 22.
Artigo em Inglês | MEDLINE | ID: mdl-38033798

RESUMO

As an important class of platform molecules, planar chiral ferrocene carbonyl compounds could be transformed into various functional groups offering facile synthesis of chiral ligands and catalysts. However, developing efficient and straightforward methods for accessing enantiopure planar chiral ferrocene carbonyl compounds, especially ferroceneformaldehydes, remains highly challenging. Herein, we report a rhodium(I)/phosphoramidite-catalyzed enantioselective C-H bond arylation of ferroceneformaldehydes. Readily available aryl halides such as aryl iodides, aryl bromides, and even aryl chlorides are suitable coupling partners in this transformation, leading to a series of planar chiral ferroceneformaldehydes in good yields and excellent enantioselectivity (up to 83% yield and >99% ee). The aldehyde group could be transformed into diverse functional groups smoothly, and enantiopure Ugi's amine and PPFA analogues could be synthesized efficiently. The latter was found to be a highly efficient ligand in Pd-catalyzed asymmetric allylic alkylation reactions. Mechanistic experiments supported the formation of imine intermediates as the key step during the reaction.

3.
Chem Rev ; 123(16): 10079-10134, 2023 Aug 23.
Artigo em Inglês | MEDLINE | ID: mdl-37527349

RESUMO

This review summarizes the advancements in rhodium-catalyzed asymmetric C-H functionalization reactions during the last two decades. Parallel to the rapidly developed palladium catalysis, rhodium catalysis has attracted extensive attention because of its unique reactivity and selectivity in asymmetric C-H functionalization reactions. In recent years, Rh-catalyzed asymmetric C-H functionalization reactions have been significantly developed in many respects, including catalyst design, reaction development, mechanistic investigation, and application in the synthesis of complex functional molecules. This review presents an explicit outline of catalysts and ligands, mechanism, the scope of coupling reagents, and applications.

4.
J Am Chem Soc ; 145(8): 4765-4773, 2023 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-36787487

RESUMO

Mechanism-guided reaction development is a well-appreciated research paradigm in chemistry since the merging of mechanistic knowledge would accelerate the discovery of new synthetic methods. Low-valent transition metals such as Pd(0)- and Rh(I)-catalyzed C-H arylation with aryl (pseudo)halides is among the enabling reactions for the exclusive cross-coupling of two different aryl partners. However, different from the situation of Pd(0)-catalysis, the mechanism of Rh(I)-catalyzed C-H arylation is underexplored. The sequence of the elementary steps of aryl C-H activation and oxidative addition of aryl (pseudo)halides remains unclear. Herein, we report comprehensive experimental and computational studies toward explicit mechanistic understandings of Rh(I)-catalyzed intermolecular asymmetric C-H arylation between 2-pyridinylferrocenes and aryl bromides. The identification of each elementary step in the catalytic cycle and the structural characterization of the key intermediates and transition states allow the rational design and development of challenging intramolecular reactions. The successful realization of this reaction mode set the foundation for the facile synthesis of planar chiral [m]ferrocenophanes (m = 6-8), a class of rarely explored target molecules with strained structures and intriguing molecular topology.

5.
Org Lett ; 24(20): 3620-3625, 2022 May 27.
Artigo em Inglês | MEDLINE | ID: mdl-35575309

RESUMO

The Rh(III)-catalyzed highly enantioselective C2-arylation of indole derivatives with 1-diazonaphthoquinones is reported. In the presence of 2.5 mol % SCpRh complex and 20 mol % AgNO3, the C2-arylation reactions of indoles proceeded smoothly, affording a wide range of C2-arylated indole atropisomers in good yields and enantioselectivity (≤96% yield, ≤97% ee) under mild conditions. The method displays a broad substrate scope and good functional group tolerance.

6.
Bioorg Chem ; 72: 116-122, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28411406

RESUMO

In our efforts to develop novel dual c-Met/VEGFR-2 inhibitors as potential anticancer agents, a series of 2-substituted-4-(2-fluorophenoxy) pyridine derivatives bearing pyrazolone scaffold were designed and synthesized. The cell proliferation assay in vitro demonstrated that most target compounds had inhibition potency on both c-Met and VEGFR-2, especially compound 9h, 12b and 12d. Based on the further enzyme assay in vitro, compound 12d was considered as the most promising one, the IC50 values of which were 0.11µM and 0.19µM for c-Met and VEGFR-2, respectively. Further molecular docking studies suggested a common mode of interaction at the ATP-binding site of c-Met and VEGFR-2, indicating that 12d was a potential compound for cancer therapy deserving further study.


Assuntos
Inibidores de Proteínas Quinases/farmacologia , Proteínas Proto-Oncogênicas c-met/antagonistas & inibidores , Pirazolonas/farmacologia , Piridinas/farmacologia , Triazóis/farmacologia , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/antagonistas & inibidores , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Relação Dose-Resposta a Droga , Descoberta de Drogas , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Humanos , Modelos Moleculares , Estrutura Molecular , Inibidores de Proteínas Quinases/síntese química , Inibidores de Proteínas Quinases/química , Proteínas Proto-Oncogênicas c-met/metabolismo , Pirazolonas/química , Piridinas/síntese química , Piridinas/química , Relação Estrutura-Atividade , Triazóis/química , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...